General Information of Disease (ID: DISIXWT1)

Disease Name Osteoporosis-pseudoglioma syndrome
Synonyms
Ops; pseudoglioma with bone fragility; osteogenesis imperfecta, ocular form; osteoporosis pseudoglioma syndrome; osteogenesis imperfecta ocular form; OPPG; osteoporosis-pseudoglioma syndrome; ocular form of osteogenesis imperfecta
Definition Osteoporosis pseudoglioma syndrome is a very rare autosomal recessive disorder characterized by congenital or infancy-onset blindness and severe juvenile-onset osteoporosis and spontaneous fractures.
Disease Hierarchy
DIS6SVEE: Syndromic disease
DISCPWH9: Autosomal recessive disease
DISEOED3: Osteogenesis imperfecta and a reduction of bone mineral density.
DIST86NS: Congenital vitreoretinal dysplasia
DISVGTB6: LRP5-related exudative vitreoretinopathy
DISIXWT1: Osteoporosis-pseudoglioma syndrome
Disease Identifiers
MONDO ID
MONDO_0009820
MESH ID
C536063
UMLS CUI
C0432252
OMIM ID
259770
MedGen ID
98480
Orphanet ID
2788
SNOMED CT ID
254112001

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 5 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
LRP6 TTSXOWE Strong Biomarker [1]
SOST TTYRO4F Strong Biomarker [1]
LRP5 TT7VMG4 Definitive Autosomal recessive [2]
LRP5 TT7VMG4 Definitive Genetic Variation [3]
TCIRG1 TTVRN05 Definitive Genetic Variation [4]
------------------------------------------------------------------------------------
This Disease Is Related to 3 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
INPPL1 OTCDAVBQ Strong Genetic Variation [5]
TSPAN12 OTF9I3CX Strong Genetic Variation [6]
LRP5 OTCC4JPH Definitive Autosomal recessive [2]
------------------------------------------------------------------------------------

References

1 Application of anti-Sclerostin therapy in non-osteoporosis disease models.Bone. 2017 Mar;96:18-23. doi: 10.1016/j.bone.2016.10.018. Epub 2016 Oct 22.
2 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001 Nov 16;107(4):513-23. doi: 10.1016/s0092-8674(01)00571-2.
3 Exploiting the WNT Signaling Pathway for Clinical Purposes.Curr Osteoporos Rep. 2017 Jun;15(3):153-161. doi: 10.1007/s11914-017-0357-0.
4 Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13.J Bone Miner Res. 2002 Jun;17(6):1111-7. doi: 10.1359/jbmr.2002.17.6.1111.
5 Fibroblasts derived from patients with opsismodysplasia display SHIP2-specific cell migration and adhesion defects.Hum Mutat. 2017 Dec;38(12):1731-1739. doi: 10.1002/humu.23321. Epub 2017 Sep 21.
6 Simultaneous Novel Mutations of LRP5 and TSPAN12 in a Case of Familial Exudative Vitreoretinopathy.J Pediatr Ophthalmol Strabismus. 2016 Feb 4;53 Online:e1-5. doi: 10.3928/01913913-20151215-01.